Enhancing cell therapies using microfluidic encapsulation strategies
使用微流体封装策略增强细胞治疗
基本信息
- 批准号:549626-2020
- 负责人:
- 金额:$ 24.09万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Collaborative Health Research Projects
- 财政年份:2020
- 资助国家:加拿大
- 起止时间:2020-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cell-based therapies hold tremendous potential to repair damaged tissue but the central
problem confronting ALL cell-based therapeutics lies in promoting meaningful long-term
engraftment of transplanted cells. Recently, we developed a novel microfluidic platform to
encapsulate cardiovascular progenitor cells in protective hydrogel cocoons, promoting cell
viability while improving engraftment within injured tissue and providing markedly improved
therapeutic benefits. However, this therapeutic effect is ultimately ephemeral as transplanted
egress their protective hydrogel microcapsules rapidly and typically fail to be retained for
more than a few additional days in the targeted tissue, thus limiting their full therapeutic
impact. Our vision is to overcome these limitations by exploiting the ability of cell-type specific
biomaterials and by using novel microencapsulation strategies to extend cell viability, while
ensuring tissue persistence upon engraftment, ultimately promoting therapeutic repair of
injured tissue. With broad implications in cellular therapeutics, we have found that this is
particularly relevant to chronic lung disease of prematurity, the main complication of preterm
birth, to the treatment of pulmonary arterial hypertension (PAH), and to cardiac injury repair,
in which we have shown the protective effects of MSCs, EPCs and EDCs in vivo. We are
working with Northern Therapeutics, a Canadian biotechnology company, to ensure this
research will be widely applicable to the field of regenerative medicine, be of marked benefit
to chronically ill patients, aide in the global competitiveness of a Canadian company, and
stimulate economic development in Canada in an emerging new market.
细胞疗法在修复受损组织方面具有巨大的潜力
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Godin, Michel其他文献
Programmable DNA Nanoswitch Sensing with Solid-State Nanopores
- DOI:
10.1021/acssensors.9b01053 - 发表时间:
2019-09-01 - 期刊:
- 影响因子:8.9
- 作者:
Beamish, Eric;Tabard-Cossa, Vincent;Godin, Michel - 通讯作者:
Godin, Michel
Measuring Single-Cell Phenotypic Growth Heterogeneity Using a Microfluidic Cell Volume Sensor
- DOI:
10.1038/s41598-018-36000-3 - 发表时间:
2018-12-13 - 期刊:
- 影响因子:4.6
- 作者:
Jing, Wenyang;Camellato, Brendan;Godin, Michel - 通讯作者:
Godin, Michel
Protective Effect of Mycophenolate Mofetil on Endothelial Function in an Aortic Allograft Model
- DOI:
10.1097/tp.0b013e3181fe12d6 - 发表时间:
2011-01-15 - 期刊:
- 影响因子:6.2
- 作者:
Freguin-Bouilland, Caroline;Godin, Michel;Joannides, Robinson - 通讯作者:
Joannides, Robinson
Using buoyant mass to measure the growth of single cells.
- DOI:
10.1038/nmeth.1452 - 发表时间:
2010-05 - 期刊:
- 影响因子:48
- 作者:
Godin, Michel;Delgado, Francisco Feijo;Son, Sungmin;Grover, William H.;Bryan, Andrea K.;Tzur, Amit;Jorgensen, Paul;Payer, Kris;Grossman, Alan D.;Kirschner, Marc W.;Manalis, Scott R. - 通讯作者:
Manalis, Scott R.
Strategies for controlling egress of therapeutic cells from hydrogel microcapsules
- DOI:
10.1002/term.2818 - 发表时间:
2019-04-01 - 期刊:
- 影响因子:3.3
- 作者:
Benavente-Babace, Ainara;Haase, Kristina;Godin, Michel - 通讯作者:
Godin, Michel
Godin, Michel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Godin, Michel', 18)}}的其他基金
Interrogating and Manipulating Biological Material at Small Scales
小规模询问和操纵生物材料
- 批准号:
RGPIN-2020-05012 - 财政年份:2022
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Individual
Interrogating and Manipulating Biological Material at Small Scales
小规模询问和操纵生物材料
- 批准号:
RGPAS-2020-00126 - 财政年份:2022
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
Interrogating and Manipulating Biological Material at Small Scales
小规模询问和操纵生物材料
- 批准号:
RGPIN-2020-05012 - 财政年份:2021
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Individual
Interrogating and Manipulating Biological Material at Small Scales
小规模询问和操纵生物材料
- 批准号:
RGPAS-2020-00126 - 财政年份:2021
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
Interrogating and Manipulating Biological Material at Small Scales
小规模询问和操纵生物材料
- 批准号:
RGPIN-2020-05012 - 财政年份:2020
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Individual
Interrogating and Manipulating Biological Material at Small Scales
小规模询问和操纵生物材料
- 批准号:
RGPAS-2020-00126 - 财政年份:2020
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
Microfluidic and Nanofluidic Biotechnologies for Applications in the Health Sciences
微流控和纳流控生物技术在健康科学中的应用
- 批准号:
RGPIN-2014-06377 - 财政年份:2019
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Individual
Microfluidic and Nanofluidic Biotechnologies for Applications in the Health Sciences
微流控和纳流控生物技术在健康科学中的应用
- 批准号:
RGPIN-2014-06377 - 财政年份:2017
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Individual
Microfluidic and Nanofluidic Biotechnologies for Applications in the Health Sciences
微流控和纳流控生物技术在健康科学中的应用
- 批准号:
RGPIN-2014-06377 - 财政年份:2016
- 资助金额:
$ 24.09万 - 项目类别:
Discovery Grants Program - Individual
Cocooning Therapeutic Cells
茧化治疗细胞
- 批准号:
478517-2015 - 财政年份:2015
- 资助金额:
$ 24.09万 - 项目类别:
Collaborative Health Research Projects
相似国自然基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
- 批准号:QN25H220002
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
- 批准号:TGY24H080011
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
- 批准号:82305053
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
- 批准号:82371634
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
- 批准号:82371799
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
- 批准号:82371616
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
- 批准号:82371145
- 批准年份:2023
- 资助金额:46.00 万元
- 项目类别:面上项目
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
- 批准号:82370976
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
- 批准号:82370923
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
相似海外基金
Enhancing triple negative breast cancer response to immune checkpoint inhibitor therapy via targeted therapies
通过靶向治疗增强三阴性乳腺癌对免疫检查点抑制剂治疗的反应
- 批准号:
10607065 - 财政年份:2023
- 资助金额:
$ 24.09万 - 项目类别:
Enhancing cell therapies using microfluidic encapsulation strategies
使用微流体封装策略增强细胞治疗
- 批准号:
549626-2020 - 财政年份:2022
- 资助金额:
$ 24.09万 - 项目类别:
Collaborative Health Research Projects
Enhancing the potency of mesenchymal stem cell therapies for kidney diseases using lab-on-a-particle technology
使用粒子实验室技术增强间充质干细胞治疗肾脏疾病的效力
- 批准号:
10373803 - 财政年份:2021
- 资助金额:
$ 24.09万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10737774 - 财政年份:2020
- 资助金额:
$ 24.09万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10672912 - 财政年份:2020
- 资助金额:
$ 24.09万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10533542 - 财政年份:2020
- 资助金额:
$ 24.09万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10024878 - 财政年份:2020
- 资助金额:
$ 24.09万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10263244 - 财政年份:2020
- 资助金额:
$ 24.09万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10416044 - 财政年份:2020
- 资助金额:
$ 24.09万 - 项目类别:
Enhancing cell therapies using microfluidic encapsulation strategies
使用微流体封装策略增强细胞治疗
- 批准号:
415684 - 财政年份:2019
- 资助金额:
$ 24.09万 - 项目类别:
Operating Grants